English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.

Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport  
July 15, 2024 21:00 HKT/SGT
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025  
July 15, 2024 19:00 HKT/SGT
Telin and BW Digital to enhance DC-to-DC connectivity with new Indonesia - Singapore cable  
July 15, 2024 17:50 HKT/SGT
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency  
July 15, 2024 17:10 HKT/SGT
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate  
Monday, July 15, 2024 3:58:00 PM
DENSO Hosts Software Strategy Briefing, Shares Company Direction  
Monday, July 15, 2024 2:05:00 PM
The Malaysian Aviation Commission Handpicks TransNusa as One of Two Foreign Airlines to Launch Flights from Subang Airport  
July 15, 2024 14:00 HKT/SGT
foundit Survey: 52% of Singaporean organisations show responsiveness to diversity issues, highlighting key growth opportunities   
July 15, 2024 08:00 HKT/SGT
Brawijaya Academic makes Mulch from Banana Waste and Water Hyacinth   
July 15, 2024 02:00 HKT/SGT
CITIC Telecom CPC's 'AI+ Cloud Network Security' Innovation Continues to Attain Recognition for Unmatched Capabilities  
July 13, 2024 00:05 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575